1. T-cell receptor rearrangements in the skin and blood of patients in the PROCLIPI study: detection of clonal rearrangements in the skin (and blood) correlates with the B-class of MF and SS patients. (2019) Authors: Wehkamp, U.; Whittaker, S.; Servitje, O.; Berti, E.; Querfeld, C.; Bagot, M.; Stadler, R.; Stranzenbach, R.; Marschalko, M.; Busschots, A.-M.; Jost, M.; Sanches, J.; Ortiz-Romero, P.; Estrach, T.; Vakeva, L.; Jonak, C.; Akilov, O.; Hodak, E.; Mitteldorf, C.; Bates, A. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FINAL DATA FROM THE PHASE 3 ALCANZA STUDY: BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN PATIENTS (PTS) WITH CD30‐POSITIVE (CD30+) CUTANEOUS T‐CELL LYMPHOMA (CTCL). (12th June 2019) Authors: Horwitz, S.M.; Scarisbrick, J.; Prince, H.M.; Whittaker, S.; Duvic, M.; Kim, Y.H.; Quaglino, P.; Zinzani, P.L.; Bechter, O.; Eradat, H.; Pinter‐Brown, L.; Akilov, O.; Geskin, L.; Sanches, J.; Ortiz‐Romero, P.; Lisano, J.; Brown, L.; Palanca‐Wessels, M.C.; Gautam, A.; Bunn, V. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PATIENT‐REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA: RESULTS FROM THE PHASE 3 ALCANZA STUDY. (June 2017) Authors: Prince, H.M.; Dummer, R.; Whittaker, S.; Horwitz, S.; Duvic, M.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.L.; Wolter, P.; Sanches, J.; Ortiz‐Romero, P.; Akilov, O.; Geskin, L.; Huen, A.; Wang, Y.; Palanca‐Wessels, M.C.; Richhariya, A.; Feliciano, J.; Zhu, Y.; Lin, H. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RESPONSE BY STAGE IN CD30‐POSITIVE (CD30+) CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS RECEIVING BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN THE PHASE 3 ALCANZA STUDY. (June 2017) Authors: Horwitz, S.; Whittaker, S.; Duvic, M.; Dummer, R.; Kim, Y.H.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.; Wolter, P.; Eradat, H.; Sanches, J.; Ortiz‐Romero, P.; Akilov, O.; Trotman, J.; Taylor, K.; Dalle, S.; Weichenthal, M.; Walewski, J.; Fisher, D.; Wang, Y. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Physician perceptions and experience of current treatment in actinic keratosis. (27th July 2014) Authors: Stockfleth, E.; Peris, K.; Guillen, C.; Cerio, R.; Basset‐Seguin, N.; Foley, P.; Sanches, J.; Culshaw, A.; Erntoft, S.; Lebwohl, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 2(2015:Feb.) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (18th February 2021) Authors: Quaglino, P.; Prince, H.M.; Cowan, R.; Vermeer, M.; Papadavid, E.; Bagot, M.; Servitjie, O.; Berti, E.; Guenova, E.; Stadler, R.; Querfeld, C.; Busschots, A.M.; Hodak, E.; Patsatsi, A.; Sanches, J.; Maule, M.; Yoo, J.; Kevin, M.; Fava, P.; Ribero, S. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (1st April 2021) Authors: Quaglino, P.; Prince, H.M.; Cowan, R.; Vermeer, M.; Papadavid, E.; Bagot, M.; Servitjie, O.; Berti, E.; Guenova, E.; Stadler, R.; Querfeld, C.; Busschots, A.M.; Hodak, E.; Patsatsi, A.; Sanches, J.; Maule, M.; Yoo, J.; Kevin, M.; Fava, P.; Ribero, S. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Atomic force microscopy and graph analysis to study the P-cadherin/SFK mechanotransduction signalling in breast cancer cells. Issue 46 (16th November 2016) Authors: Ribeiro, A. S.; Carvalho, F. A.; Figueiredo, J.; Carvalho, R.; Mestre, T.; Monteiro, J.; Guedes, A. F.; Fonseca, M.; Sanches, J.; Seruca, R.; Santos, N. C.; Paredes, J. Journal: Nanoscale Issue: Volume 8:Issue 46(2016) Page Start: 19390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Physician perceptions and experience of current treatment in actinic keratosis. (27th July 2014) Authors: Stockfleth, E.; Peris, K.; Guillen, C.; Cerio, R.; Basset‐Seguin, N.; Foley, P.; Sanches, J.; Culshaw, A.; Erntoft, S.; Lebwohl, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 2(2015:Feb.) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗